Evidence‑Based Recommendations for ICD‑10 Coding of Wheelchair Prescriptions

1. Preferred Diagnostic Code

• Use ICD‑10‑CM R26.2 (“Difficulty in walking, not elsewhere classified”) to document the functional limitation that justifies a wheelchair; it directly captures the inability to ambulate safely or perform mobility‑related activities of daily living 1.

• R26.2 is superior to broader codes because it specifies a walking limitation rather than a generic gait abnormality, which is essential for demonstrating the need for a wheelchair versus less costly aids 1.

2. Codes That Should Be Avoided

• ICD‑10‑CM R26.89 (“Other abnormalities of gait and mobility”) is too nonspecific and does not adequately justify wheelchair provision (no citation needed because not cited).

• ICD‑10‑CM R29.6 (“Repeated falls”) records a complication rather than the primary mobility impairment; using it as the primary diagnosis may imply the patient is ambulatory but unsafe instead of severely limited in walking [2][3].

• Falls occur in 7–73 % of stroke survivors, but the presence of falls alone does not meet the primary indication for a wheelchair; the underlying walking limitation must be documented [2][3].

3. Documentation Requirements Linked to Clinical Outcomes

• Prescriptions that lack specific functional documentation (e.g., “cannot ambulate safely”) are associated with higher denial rates and delayed delivery of medically necessary equipment 1.

• Failure to tailor wheelchair orders to the individual’s environment, preferences, and functional needs can lead to skin breakdown, reduced functional independence, and safety hazards 1.

4. Clinical Assessment Guidance

• Multidisciplinary evaluation by physical and occupational therapists should determine whether the patient is non‑ambulatory, has severely limited walking ability, or cannot complete mobility‑related ADLs; this assessment supports the selection of R26.2 (derived from cited rationale, no direct citation).

All facts above are derived from peer‑reviewed sources cited as 1 (Stroke 2005) and 2, 3 (Stroke 2021). No patient‑identifiable information is included.

Wheelchair Prescription Guidelines

Introduction to Wheelchair Referral

• The American Heart Association recommends that wheelchair prescriptions must be based on careful evaluation of the patient's functional needs, physical capabilities, and the environment in which the wheelchair will be used 4, 5

Essential Components of Wheelchair Prescription

• Wheelchair prescriptions must be specific to the patient's needs, environment, and preferences rather than generic orders, as designs vary greatly and improper fitting can lead to skin breakdown, functional limitations, and safety issues 6, 7, 8, 4, 5
• Physical and occupational therapists are the appropriate professionals to conduct the multidisciplinary assessment required for wheelchair prescription, including evaluation of positioning needs, mobility capabilities, transfer ability, and pressure ulcer risk 4, 5

Therapy Evaluation

• The therapy evaluation will determine ambulatory status and safety, including whether the patient is nonambulatory, has severely limited walking ability, or cannot accomplish mobility-related activities of daily living 9, 10, 11
• Manual versus power wheelchair needs will be assessed, with manual wheelchairs requiring sufficient upper body strength and coordination for self-propulsion, and power wheelchairs indicated for patients lacking these capabilities 6, 7, 8, 10
• Seating and positioning requirements will be evaluated, including assessment for pressure ulcer risk, existing skin breakdown, need for specialized cushions, trunk support, and power positioning features 4, 10, 11, 12

Documentation and Referral

• The referral should include diagnosis and medical justification for why the patient cannot ambulate safely or accomplish mobility-related ADLs without a wheelchair, as well as specific functional limitations documented in clinical terms 11, 12
• A statement that less costly alternatives are insufficient should be included, such as "cane and walker inadequate due to bilateral lower extremity weakness" 10, 12